AbbVie’s Rinvoq is first JAK drug cleared in EU for atopic dermatitis

The FDA may be reluctant to trust JAK inhibitors, but the European Commission is more willing, and has just handed a first-in-class approval in atopic dermatitis to AbbVie’s Rinvoq.